VulnerabilityModified
CVE-2017-12720
An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6.
HIGH 8.1EPSS 1.85%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.85%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The FTP server on the pump does not require authentication if the pump is configured to allow FTP connections.
- CVSS 3.0
- 8.1 HIGHCVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.85% probability · 78th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-306
- Affected
- smiths-medical/medfusion 4000 wireless syringe infusion pump
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/100665Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02AThird Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.